1.
Arq Bras Cardiol
; 59(2): 113-7, 1992 Aug.
Artículo
en Portugués
| MEDLINE
| ID: mdl-1341156
RESUMEN
PURPOSE: To comprove the efficiency of acetyl salicylic acid (ASA) as platelet antiaggregant drug, a 100 mg/day dose base. METHODS: Two hundred and fifty-eight patients were studied between 1988 and 1990. Platelet functions were measured using an aggregometer plus ADP 5 as platelet aggregation inductor. RESULTS: Two groups were studied: 1st group, using ASA (111 patients), 91 hypoaggregants; 2nd group, not using ASA (147 patients), 120 normals, 12 hypoaggregants and 15 hyperaggregants. From the 2nd group, 91 had another evaluation under the use of ASA and showed a clear effect of the drug. CONCLUSION: The use of aspirin, 100 mg/day dose, is enough to reduce platelet antiaggregation.
Asunto(s)
Aspirina/administración & dosificación , Adolescente , Adulto , Anciano , Niño , Evaluación de Medicamentos , Cardiopatías/sangre , Cardiopatías/tratamiento farmacológico , Hemostasis/efectos de los fármacos , Humanos , Hipertensión/sangre , Hipertensión/tratamiento farmacológico , Persona de Mediana Edad , Agregación Plaquetaria/efectos de los fármacos
2.
Minerva Med
; 60(59): 2895-904, 1969 Jul 28.
Artículo
en Italiano
| MEDLINE
| ID: mdl-5795382
3.
Munch Med Wochenschr
; 111(25): 1379-85, 1969 Jun 20.
Artículo
en Alemán
| MEDLINE
| ID: mdl-5820230